Harmony Biosciences Holdings, Inc.
HRMY stock score: 68/100
$36.03 · -5.95% · Scored Oct 22, 2026
- Technical
- 53
- Fundamental
- 82
- News
- 52
The reading
Harmony Biosciences (HRMY) scores 68 out of 100, which reads bullish, higher than 98% of Healthcare stocks and 95% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 53, fundamentals 82.
Among the fundamentals, Fair Value at 100 and Inventory Turnover at 100 score highest, while Insider Transactions at 35 weighs the most against it.
On the daily chart, trend-following indicators average 31 and contrarian oscillators 62 — a split worth reading before trusting the technical total.
News sentiment is neutral at 52; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 62 to 80, and it is down 11 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward HRMY’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
82Pulling it up
- Fair Value100
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- Inventory Turnover100
Inventory turnover is how many times a year a company sells through its inventory.
- Institutional Ownership100
Institutional ownership measures the percentage held by professional investors.
Holding it back
- Insider Transactions35
Insider transactions track recent buying and selling by company insiders.
- Earnings Growth (Annual)43
Annual earnings growth tracks year-over-year profit expansion.
39 weighted scorers; 2 had no data today and are left out rather than counted as zero.
Technical · daily
37Pulling it up
- Bollinger Bands (20)100
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- Bollinger Bands (50)100
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
- 52-Week Change79
The price change over the last 52 weeks.
Holding it back
- Candlestick Patterns0
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
- Performance vs SPY0
Performance versus SPY compares the stock's returns to the S&P 500 index.
- VWAP0
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 52
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 35 | 1 |
| Daily | 37 | 3 |
| Weekly | 58 | 2 |
| Monthly | 66 | 2 |
| Quarterly | 67 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 68 |
| Oct 21, 2026 | 72 |
| Oct 20, 2026 | 72 |
| Oct 19, 2026 | 70 |
| Oct 18, 2026 | 71 |
| Oct 17, 2026 | 71 |
| Oct 16, 2026 | 71 |
| Oct 15, 2026 | 71 |
| Oct 14, 2026 | 69 |
| Oct 13, 2026 | 69 |
| Oct 12, 2026 | 70 |
| Oct 11, 2026 | 74 |
| Oct 10, 2026 | 74 |
| Oct 9, 2026 | 74 |
| Oct 8, 2026 | 73 |
| Oct 7, 2026 | 72 |
| Oct 6, 2026 | 72 |
| Oct 5, 2026 | 73 |
| Oct 4, 2026 | 73 |
| Oct 3, 2026 | 73 |
| Oct 2, 2026 | 73 |
| Oct 1, 2026 | 72 |
| Sep 30, 2026 | 71 |
| Sep 29, 2026 | 71 |
| Sep 28, 2026 | 72 |
| Sep 27, 2026 | 74 |
| Sep 26, 2026 | 74 |
| Sep 25, 2026 | 74 |
| Sep 24, 2026 | 75 |
| Sep 23, 2026 | 75 |
| Sep 22, 2026 | 74 |
| Sep 21, 2026 | 74 |
| Sep 20, 2026 | 73 |
| Sep 19, 2026 | 73 |
| Sep 18, 2026 | 74 |
| Sep 17, 2026 | 75 |
| Sep 16, 2026 | 75 |
| Sep 15, 2026 | 75 |
| Sep 14, 2026 | 74 |
| Sep 13, 2026 | 74 |
| Sep 12, 2026 | 74 |
| Sep 11, 2026 | 74 |
| Sep 10, 2026 | 73 |
| Sep 9, 2026 | 75 |
| Sep 8, 2026 | 75 |
| Sep 7, 2026 | 75 |
| Sep 6, 2026 | 76 |
| Sep 5, 2026 | 76 |
| Sep 4, 2026 | 75 |
| Sep 3, 2026 | 74 |
| Sep 2, 2026 | 75 |
| Sep 1, 2026 | 75 |
| Aug 31, 2026 | 73 |
| Aug 30, 2026 | 74 |
| Aug 29, 2026 | 74 |
| Aug 28, 2026 | 74 |
| Aug 27, 2026 | 75 |
| Aug 26, 2026 | 74 |
| Aug 25, 2026 | 74 |
| Aug 24, 2026 | 73 |
| Aug 23, 2026 | 73 |
| Aug 22, 2026 | 73 |
| Aug 20, 2026 | 72 |
| Aug 19, 2026 | 74 |
| Aug 18, 2026 | 72 |
| Aug 17, 2026 | 72 |
| Aug 16, 2026 | 72 |
| Aug 15, 2026 | 72 |
| Aug 14, 2026 | 72 |
| Aug 13, 2026 | 74 |
| Aug 12, 2026 | 74 |
| Aug 11, 2026 | 74 |
| Aug 10, 2026 | 74 |
| Aug 9, 2026 | 73 |
| Aug 8, 2026 | 73 |
| Aug 7, 2026 | 71 |
| Aug 6, 2026 | 65 |
| Aug 5, 2026 | 65 |
| Aug 3, 2026 | 64 |
| Aug 2, 2026 | 62 |
| Jul 31, 2026 | 75 |
| Jul 30, 2026 | 76 |
| Jul 29, 2026 | 76 |
| Jul 28, 2026 | 80 |
| Jul 27, 2026 | 80 |
| Jul 26, 2026 | 79 |
| Jul 25, 2026 | 79 |
Key facts
- Market cap
- $2.1B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.01
- Risk grade (1–10)
- 10
- Next earnings
- Nov 4, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| CLDX Celldex Therapeutics | $2.3B | 32 |
| FTRE Fortrea | $2.3B | 53 |
| AUPH Aurinia Pharmaceuticals | $2.2B | 76 |
| VERA Vera Therapeutics | $2.2B | 38 |
| AGIO Agios Pharmaceuticals | $2.2B | 49 |
| PHVS Pharvaris | $2.2B | 43 |
Questions
What is HRMY's stock score today?
HRMY scores 68/100 (Bullish) as of Oct 22, 2026: technical 53, fundamental 82, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.
Is HRMY a buy?
The score is not a buy or sell recommendation. A 68 says the technical and fundamental signals we measure lean bullish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the HRMY score calculated?
101 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.